{"id":55552,"date":"2022-12-23T14:57:10","date_gmt":"2022-12-23T14:57:10","guid":{"rendered":"https:\/\/touchoncology.com\/?post_type=media_gallery&p=55552"},"modified":"2022-12-23T14:57:10","modified_gmt":"2022-12-23T14:57:10","slug":"sudeep-gupta-sabcs-2022-addition-of-platinum-to-neoadjuvant-chemotherapy-in-patients-with-triple-negative-breast-cancer-a-phase-iii-randomized-controlled-trial","status":"publish","type":"media_gallery","link":"https:\/\/touchoncology.com\/breast-cancer\/conference-hub\/sudeep-gupta-sabcs-2022-addition-of-platinum-to-neoadjuvant-chemotherapy-in-patients-with-triple-negative-breast-cancer-a-phase-iii-randomized-controlled-trial\/","title":{"rendered":"Sudeep Gupta, SABCS 2022: Addition of platinum to neoadjuvant chemotherapy in patients with triple-negative breast cancer: A phase III randomized controlled trial"},"content":{"rendered":"
The impact of adding platinum on long-term outcomes in triple-negative breast cancer\u00a0<\/span>(TNBC) has not been definitively established. The controlled, single-centre, phase III study conducted by Tata Memorial Hospital in Mumbai, India evaluated the efficacy and toxicity of adding platinum to standard neoadjuvant chemotherapy in patients with triple-negative breast cancer. In this touchONCOLOGY interview, we speak with Dr Sudeep Gupta <\/b>(Tata Memorial Hospital, Mumbai, India) who discusses the rationale for adding carboplatin to standard neoadjuvant chemotherapy in patients with triple-negative breast cancer and<\/span>\u00a0gives an overview of his phase III study.<\/p>\n The abstract entitled \u2018Addition of platinum to sequential taxane-anthracycline neoadjuvant chemotherapy in patients with triple-negative breast cancer: A phase III randomized controlled trial<\/span><\/span>\u2019 was presented at San Antonio Breast Cancer Symposium\u00a0(SABCS)<\/a>, 06\u201310, December, 2022.<\/span><\/p>\n Questions<\/b>:<\/span><\/p>\n Disclosures<\/b>: Sudeep Gupta has nothing to disclose in relation to this video interview.<\/span><\/p>\n Support<\/b>: Interview and filming supported by Touch Medical Media. Interview conducted by Shanice Allen<\/span><\/p>\n Filmed as a highlight of <\/i><\/b>SABCS 2022<\/i><\/b><\/a><\/p>\n\n
\n<\/span><\/li>\n
\n<\/span><\/li>\n
\n<\/span><\/li>\n
\n<\/span><\/li>\n